Larimar stock falls on adverse events despite positive data
On Monday, shares of Larimar Therapeutics experienced a significant decline following a data update from its ongoing Friedreich’s ataxia treatment study. The update included...
On Monday, shares of Larimar Therapeutics experienced a significant decline following a data update from its ongoing Friedreich’s ataxia treatment study. The update included...
-- IT hardware spending is set for a turnaround in 2025 after a dour 2024, driven by a recovery in both enterprise and consumer markets, according to a Morgan...
On Monday, telecom giants AT&T (NYSE:T), Verizon (NYSE:VZ), and Comcast (NASDAQ:CMCSA) saw their shares decline following the Supreme Court's decision not to hear an appeal...
-- Shares of AeroVironment Inc. (NASDAQ:AVAV) climbed 9.6% following the US Government Accountability Office's (GAO) decision to deny a protest against the...
Shares of Sangamo Therapeutics experienced a significant surge, climbing as much as 36%, following the announcement that pharmaceutical giant Roche has discontinued its gene...
--BofA Securities upgraded Ambarella Inc (NASDAQ:AMBA) to “neutral” from “underperform,” with the price target raised to $80 from $65, on expected growth...
--Loop Capital upgraded Netflix Inc (NASDAQ:NFLX) to "buy" from "hold," given its robust subscriber growth, mid-teens revenue growth, and a strong slate of upcoming...
Monday's market has seen significant movements in various stocks, with mega-cap names like Avago Technologies (NASDAQ:AVGO) and Tesla Motors (NASDAQ:TSLA) experiencing...
By Jeff Mason and Steve Holland PALM BEACH, Florida (Reuters) -President-elect Donald Trump, with SoftBank (TYO:9984) Group CEO Masayoshi Son at his side, announced on Monday that...
As traders approach another pivotal day for financial markets, Tuesday, December 17, 2024, brings a series of crucial economic data releases that could sway market dynamics. The...